SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-012513
Filing Date
2022-09-14
Accepted
2022-09-14 16:23:14
Documents
40
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbsv_10q.htm   iXBRL 10-Q 854479
2 CERTIFICATION pbsv_ex311.htm EX-31.1 13912
3 CERTIFICATION pbsv_ex312.htm EX-31.2 10834
4 CERTIFICATION pbsv_ex321.htm EX-32.1 4544
  Complete submission text file 0001654954-22-012513.txt   2772487

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20220731.xsd EX-101.SCH 25039
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20220731_lab.xml EX-101.LAB 154438
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20220731_cal.xml EX-101.CAL 32230
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20220731_pre.xml EX-101.PRE 118930
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20220731_def.xml EX-101.DEF 41300
34 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_10q_htm.xml XML 337438
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

IRS No.: 200653570 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-50956 | Film No.: 221243237
SIC: 8742 Services-Management Consulting Services